In this retrospective study, researchers assessed whether high-dose-rate intraoperative radiotherapy can achieve high tumor control in unfavorable soft tissue sarcoma of the extremities.

Patients with pituitary adenomas treated with radiotherapy face elevated long-term mortality risks, driven primarily by CVA.

Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...

Asia Pacific to record the fastest growth. The global radiotherapy market is projected to grow from $7.98b in 2026 to $10.68b ...

Dr. Pepin concluded her presentation discussing a secondary analysis of the VISION trial assessing the impact of external ...

Post-surgery radiation therapy can significantly reduce the risk of cancer recurrence in patients with high-risk ...

It is called GammaPod and it is a state-of-the-art technology designed exclusively for breast radiotherapy, capable of ...

GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 software ...

Side effects tend to start a few days after the radiotherapy begins. They gradually get worse over the days and weeks of your treatment. They can continue to get worse after your treatment ends. They ...

According to MarketsandMarkets™, the Radiotherapy Market is projected to grow from about USD 7.98 billion in 2026 to USD ...